Dr. Ingram's presentation will consider ways to drive clinical supply efficiency through innovative packaging, manage cold chain and import/export requirement for global trials and look at why eClinical solutions are key to global supply chain management.
Catalent's Development & Clinical Services business offers clinical supply services, analytical chemistry, respiratory product development, regulatory consulting, and biologics cell line development. Catalent has made substantial recent investments to extend the capabilities and capacity of the business. Catalent today provides the broadest range of expert development services, which can drive more efficient development timelines, and help customers bring more compounds and better products to market faster.
Dr. Ingram has more than 15 years leadership experience in the clinical supplies industry. He is a Chartered Biologist and a Member of the Institute for Bio-Science with a Ph.D. from Strathclyde University in the UK.
The 3rd Annual Clinical Trial Supply China 2012 is co-located alongside China Bio/Pharma and Clinical Supply Chain Convention 2012 and the 2nd Annual Bio/Pharma Cold Chain China starting on Tuesday, February 28th and continuing the next day. Dr Ingram's presentation will take place at 11.40 am in Capital Ballroom 3 (Level 3) of the Renaissance Beijing Capital Hotel. For more information on this event, please visit www.clinicaltrialssupply.com . To schedule an interview with Dr. Ingram during or after the conference, please contact Patricia McGee or Chris Halling at [email protected].
To receive a copy of this presentation after the event, please visit us here.
Companies in this press-release
